Myocardial Wringing and Rigid Rotation in Cardiac Amyloidosis.

Background: The motion of the heart is a result of the helicoidal arrangement of the myofibers in the organ's wall. We aimed to study the relationship between the wringing motion state and the degree of ventricular function in patients with cardiac amyloidosis (CA). Methods: Fifty patients with CA and decreased global longitudinal strain (LS) were evaluated using 2-dimensional speckle-tracking echocardiography. We have expressed LS as positive values to facilitate understanding. Normal twist, which occurs when basal and apical rotations occur in opposite directions, was coded as positive. When the apex and base rotate in the same direction (rigid rotation), twist was coded as negative. Left ventricular (LV) wringing (calculated as twist/LS, which takes into account actions that occur simultaneously during LV systole [ie, longitudinal shortening and twist]) was evaluated according to LV ejection fraction (LVEF). Results: Most of the patients (66%) who participated in the study were diagnosed with transthyretin amyloidosis. A positive relationship was observed between wringing and LVEF (r = 0.75, P < 0.0001). In advanced stages of ventricular dysfunction, rigid rotation appeared in 66.6% of patients with LVEF ≤ 40%, in whom negative values of twist and wringing were observed. LV wringing proved to be a good discriminator of LVEF (area under the curve 0.90, P < 0.001, 95% confidence interval 0.79-0.97); for example, wringing < 1.30°/% detected LVEF < 50% with 85.7% sensibility and 89.7% specificity. Conclusions: Wringing, which integrates twist and simultaneous LV longitudinal shortening, is a conditioning rotational parameter of the degree of ventricular function in patients with CA.

Contexte: Les mouvements du cœur sont le résultat de l'orientation hélicoïdale des fibres des parois du cœur. L'objectif de notre étude était d'étudier le lien entre le mouvement « d'essorage ¼ et la fonction ventriculaire chez les patients atteints d'amylose cardiaque (AC). Méthodologie: Cinquante patients atteints d'AC et présentant une déformation longitudinale (DL) globale réduite ont fait l'objet d'une évaluation à l'aide de l'échocardiographie bidimensionnelle de suivi des marqueurs acoustiques. Nous avons choisi d'exprimer la DL en valeurs positives pour faciliter la compréhension des données. Une torsion normale, caractérisée par les mouvements de rotation opposés entre la base et l'apex du cœur, a été codée comme positive. Lorsque l'apex et la base opéraient une rotation dans la même direction (rotation rigide), la torsion était codée comme négative. Le mouvement « d'essorage ¼ du ventricule gauche (VG) (calculé comme le rapport torsion/DL, qui tient compte des actions survenant simultanément durant la systole du VG [c.-à-d., raccourcissement longitudinal et torsion]) a été évalué en fonction de la fraction d'éjection du VG (FEVG). Résultats: La plupart des patients (66 %) ayant participé à l'étude avaient reçu un diagnostic d'amylose à transthyrétine. Un lien positif a été établi entre le mouvement d'essorage et la FEVG (coefficient de corrélation [r] = 0,75, p < 0,0001). Aux stades avancés de la dysfonction ventriculaire, une rotation rigide a été observée chez 66,6 % des patients ayant une FEVG ≤ 40 % et chez qui les valeurs de torsion et d'essorage étaient négatives. L'essorage du VG s'est révélé être un facteur fiable de détermination de la FEVG (aire sous la courbe : 0,90; p < 0,001, intervalle de confiance [IC] à 95 % : 0,79-0,97); par exemple, un mouvement d'essorage < 1,30 °/% a permis de détecter une FEVG < 50 % avec une sensibilité de 85,7 % et une spécificité de 89,7 %. Conclusions: Le mouvement d'essorage, qui intègre simultanément la torsion et le raccourcissement longitudinal du VG, est un paramètre rotationnel qui influence le degré de fonction ventriculaire chez les patients atteints d'AC.

Can source control of pharmaceuticals decrease the investment needs in urban wastewater infrastructure?

The source control of pharmaceuticals involves influencing the everyday consumption volume and compound choice. This paper evaluates how source control contributes to protecting the environmental health and decreasing the investment needs in urban wastewater infrastructure. Different levels of reduction in diclofenac consumption (as recommended by the European Medicines Agency) compensated by equivalent increases in naproxen consumption (a less environmentally harmful compound) are evaluated. The different loads of compounds are fed into a microcontaminant fate and transport model of the Llobregat river basin (Spain) to assess the investment needs in tertiary treatment to reach diclofenac and naproxen concentrations below environmental quality standards. The results show that, despite the implementation of source control measures, tertiary treatment upgrades are still required in every scenario evaluated. Even though source control of pharmaceuticals decreases the investment needs in urban wastewater infrastructure, apparent concentrations reductions (i.e. statistically significant differences relative to the reference situation) are only observed in drastic substitutions of diclofenac by naproxen (a reduction in the total diclofenac consumption by 73% and a corresponding increase in naproxen consumption). The results also show that Spain is on good track with regards to the substitution of diclofenac by naproxen (among the top 5 in Europe), and this paper shows how positive this substitution can be for the environment.

Balancing environmental quality standards and infrastructure upgrade costs for the reduction of microcontaminant loads in rivers.

Investments for upgrading wastewater treatment plants (WWTPs) with tertiary treatment to reduce microcontaminant loads in surface waters at a catchment scale can be daunting. These investments are highly sensitive to the selection of environmental quality standards (EQSs) for the target microcontaminants. Our hypothesis is that there is a balance between EQS selection and investment that needs to be considered in decision-making. We used a customized microcontaminant fate and transport model coupled to an optimization algorithm to validate this hypothesis in the Llobregat river basin and for the pharmaceutical compound diclofenac. The algorithm optimizes the number of WWTPs in this catchment requiring an upgrade to minimize the total amount of diclofenac that exceeds the EQS in every river section and the total cost. We simulated and optimized 40 scenarios representing a combination of 4 potential EQSs (10, 30, 50 and 100 ng L-1), 5 levels of uncertainty bounds in the predictions of river concentrations and 2 hydrological scenarios (average flows, flows annually exceeding 30% of the days; and environmental flows, flows annually exceeding 99% of the days). The results showthat there is a nonlinear relationship between the EQS and the required investment. The investment increases by 100% from an EQS of 100 ng L-1 to 10 ng L-1, significantly increasing (by 60%) from 30 to 10 ng L-1. Thus, establishing an EQS of 30 ng L-1 would balance environmental protection and costs. The selection of the hydrological conditions also plays a key role in the upgrade analysis because the costs for environmental flows are 50% higher than for average flows. Finally, we highlight that the investment in research would allow the reduction of uncertainties, hence allowing more qualified decisions to be made and a reduction in the WWTP upgrade costs (up to 4 €·household-1·year-1).